查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1935509

近距离放射治疗全球市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Brachytherapy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计近距离放射治疗市场将从 2025 年的 11.7 亿美元成长到 2034 年的 22.9 亿美元，2026 年至 2034 年的复合年增长率为 7.72%。

受癌症患者数量不断增加和对标靶治疗需求日益增长的推动，近距离放射治疗市场正经历显着增长。近距离放射治疗是一种将放射性物质直接输送到肿瘤内部或附近的放射治疗方法，与传统的体外放射治疗相比，具有许多优势，包括减少周围正常组织的辐射暴露和提高治疗精度。随着医疗机构寻求改善患者预后并最大限度地减少副作用，预计近距离放射治疗的应用将会增加，从而推动该市场的强劲成长。越来越多的临床证据支持近距离放射治疗在治疗包括前列腺癌、乳癌和子宫颈癌在内的多种癌症方面的疗效，进一步佐证了这一趋势。

此外，近距离放射治疗技术的进步正在推动市场创新。新型放射性同位素的研发、改良的输送系统以及先进的影像技术的出现，提高了近距离放射治疗的有效性和安全性。这些创新不仅改善了治疗效果，也有助于简化医疗专业人员的工作流程。随着对近距离放射治疗新应用（例如与免疫疗法和其他治疗方法联合使用）的研究不断深入，预计该市场将进一步扩张，因为它有望改善患者照护效果。

此外，对个人化医疗的日益重视正在重塑近距离放射治疗的格局。随着医疗服务提供者越来越倾向于根据个别患者的情况调整治疗方案，对灵活且适应性强的近距离放射治疗解决方案的需求预计将会成长。这一趋势在晚期癌症治疗领域尤其重要，因为了解肿瘤的特定特征会显着影响治疗决策。随着近距离放射治疗市场的不断发展，技术创新、个人化治疗方法以及对改善患者预后的关注将共同推动未来的成长。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球近距离放射治疗市场（依剂型划分）

  • 市场分析、洞察与预测
  • 高剂量率（HDR）近距离放射治疗
  • 低剂量率（LDR）近距离放射治疗

5. 全球近距离放射治疗市场（依产品划分）

  • 市场分析、洞察与预测
  • 种子
  • 施用器和后荷机
  • 电子束近距离放射治疗

6. 全球近距离放射治疗市场（依应用划分）

  • 市场分析、洞察与预测
  • 摄护腺癌
  • 妇科癌症
  • 乳癌
  • 其他的

7. 全球近距离放射治疗市场（依地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Varian Medical Systems Inc
    • Becton
    • Dickinson & Company
    • Elekta AB
    • Isoray Medical Inc
    • Eckert & Ziegler BEBIG
    • ICAD Inc
    • CIVCO Medical Solutions
    • Theragenics Corporation
简介目录
Product Code: VMR11211002

The Brachytherapy Market size is expected to reach USD 2.29 Billion in 2034 from USD 1.17 Billion (2025) growing at a CAGR of 7.72% during 2026-2034.

The brachytherapy market is experiencing significant growth, driven by the increasing prevalence of cancer and the demand for targeted treatment options. Brachytherapy, a form of radiation therapy that involves placing radioactive sources directly within or near a tumor, offers several advantages over traditional external beam radiation therapy, including reduced exposure to surrounding healthy tissues and improved treatment precision. As healthcare providers seek to enhance patient outcomes and minimize side effects, the adoption of brachytherapy is expected to rise, positioning this market for robust expansion. The growing body of clinical evidence supporting the efficacy of brachytherapy in treating various cancers, including prostate, breast, and cervical cancers, is further fueling this trend.

Moreover, advancements in brachytherapy technologies are driving innovation within the market. The development of new radioactive isotopes, improved delivery systems, and advanced imaging techniques is enhancing the effectiveness and safety of brachytherapy procedures. These innovations not only improve treatment outcomes but also contribute to a more streamlined workflow for healthcare providers. As research continues to explore new applications for brachytherapy, such as in combination with immunotherapy and other treatment modalities, the market is likely to expand further, driven by the promise of improved patient care and outcomes.

Additionally, the growing emphasis on personalized medicine is shaping the brachytherapy landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable brachytherapy solutions is likely to rise. This trend is particularly relevant in the context of advanced cancer treatments, where understanding the specific characteristics of a tumor can significantly impact treatment decisions. As the brachytherapy market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Dosage Type

  • High-Dose Rate (HDR) Brachytherapy
  • Low-Dose Rate (LDR) Brachytherapy

By Product

  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy

By Application

  • Prostate Cancer
  • Gynaecological Cancer
  • Breast Cancer
  • Others

COMPANIES PROFILED

  • Varian Medical Systems Inc, Becton, Dickinson Company, Elekta AB, Isoray Medical Inc, Eckert Ziegler BEBIG, iCAD Inc, CIVCO Medical Solutions, Theragenics Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BRACHYTHERAPY MARKET: BY DOSAGE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Dosage Type
  • 4.2. High-Dose Rate (HDR) Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Low-Dose Rate (LDR) Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BRACHYTHERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Seeds Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Applicators & Afterloaders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Electronic Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BRACHYTHERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Gynaecological Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BRACHYTHERAPY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Dosage Type
    • 7.2.2 By Product
    • 7.2.3 By Application
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Dosage Type
    • 7.3.2 By Product
    • 7.3.3 By Application
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Dosage Type
    • 7.4.2 By Product
    • 7.4.3 By Application
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Dosage Type
    • 7.5.2 By Product
    • 7.5.3 By Application
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Dosage Type
    • 7.6.2 By Product
    • 7.6.3 By Application
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BRACHYTHERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Varian Medical Systems Inc
    • 9.2.2 Becton
    • 9.2.3 Dickinson & Company
    • 9.2.4 Elekta AB
    • 9.2.5 Isoray Medical Inc
    • 9.2.6 Eckert & Ziegler BEBIG
    • 9.2.7 ICAD Inc
    • 9.2.8 CIVCO Medical Solutions
    • 9.2.9 Theragenics Corporation